The incidence of and mortality from invasive melanoma in the United States has risen steadily for at least the past 2 decades. 1 Similar trends are being seen worldwide despite numerous efforts to enhance primary prevention and early detection, and these increasing rates are having an impact on the public health and economic burden of disease. In 2009, we reported on the status of US melanoma incidence at that time. 2 The purpose of this study was to provide updated information on trends in melanoma incidence and mortality that will help to elucidate the current state of this cancer in the United States.

our patients demonstrated a variable profile to the larger ERIVANCE trial, 2 the AEs in our study were not standardized and were patient reported. Our study had limitations. This was a retrospective medical record review and used a relatively small sample size and patient-reported AEs and assessed improvement based on clinical photos rather than measurement. Most importantly, none of our 7 patients terminated the medication owing to AEs.Conclusions | To our knowledge, this is the first study to demonstrate efficacy with 1-to 3-week drug holidays. An intermittent dosing schedule of vismodegib should be considered when treatment-related AEs would cause discontinuation of treatment. Dosing regimens as low as 1 week with and 3 weeks without medication continued to demonstrate clinical improvement in patients with BCCs in this cohort. Pharmacokinetic and prospective randomized clinical trials are needed to determine the ideal intermittent regimen without causing resistance.

Purpose: To set up a robust and patient-friendly wholeheart protocol based on 32-receive-channel technology that will potentially allow a large part of the patient population to be addressed. Materials and Methods:Ten volunteers were examined on a clinical 1.5 T scanner equipped with a 32-channel data acquisition system using an experimental 32-element coil array. A magnetization-prepared, navigator-gated and -tracked 3D Cartesian balanced FFE sequence was used for whole-heart coronary MR angiography (MRA). With the use of sensitivity encoding (SENSE) and partial Fourier encoding for scan acceleration, nearly isotropic high-resolution data sets were acquired during free breathing in four minutes. Results:A high contrast and sufficient signal-to-noise ratio (SNR) were obtained, which allowed visualization of the major vessels up to the distal regions and detection of major branches. Phase encoding in the anterior-posterior (AP) direction was the most favorable SENSE configuration and allowed a reasonable scan time reduction with moderate SENSE factors. Conclusion:The employed 32-receive channel technology enabled a robust trade-off among SNR, spatial resolution, and scan time. In this study the most robust results were obtained using the smallest possible SENSE factors for a given voxel size and scan time.

Parallel imaging techniques, which use several receive coils simultaneously, have been shown to enable a significant scan time reduction by subsampling k-space. Nevertheless, the data acquired with multiple coils in parallel exhibit some redundancy if the number of receive coils exceeds the subsampling factor. This redundancy leads to an overdetermination of the reconstruction problem, which is generally used to optimize the signal-to-noise ratio (SNR). However, it can yield further information about the quality of the reconstructed image, and can thus be used to identify and correct image artifacts. While some known approaches try to solve this problem in k-space, this study addresses it in the spatial domain and uses a modified SENSE reconstruction to reduce or completely remove ghosttype artifacts arising from processes such as motion or flow during data acquisition. Phantom and in vivo studies show significant improvements in image quality after correction, and serve as a basis for the discussion of the performance and limitations of this new approach. Magn Reson Med 54: 1002-1009, 2005.

No abstract